SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549
Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934
Date of Report (Date of earliest event reported)
(Exact name of registrant as specified in its charter)
(State or other jurisdiction of
(Address of principal executive offices)
Registrant’s telephone number, including area code (
(Former name or former address, if changed since last report)
Check the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the filing obligation of the registrant under any of the following provisions:
Securities registered pursuant to Section 12(b) of the Act:
Title of each class
Name of each exchange on which registered
Indicate by check mark whether the registrant is an emerging growth company as defined in Rule 405 of the Securities Act of 1933 (§230.405 of this chapter) or Rule 12b-2 of the Securities Exchange of 1934 (§240.12b-2 of this chapter).
Emerging growth company
If an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying with any new or revised financial accounting standards provided pursuant to Section 13(a) of the Exchange Act.☐
Item 5.02 Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers; Compensatory Arrangements of Certain Officers
On August 18, 2020, the Board of Directors of C&F Financial Corporation (the “Corporation”), appointed Dr. Jeffery O. Smith to serve as a director of the Corporation effective September 15, 2020. Dr. Smith will serve as a director of the Corporation until the annual meeting of shareholders in 2021, at which time he will stand for election as a Class I director. Dr. Smith has also been appointed to serve on the Corporation’s Nominating Committee.
There are no arrangements or understandings between Dr. Smith and any other person pursuant to which he was selected as a director. Dr. Smith will be compensated for his services as a director of the Corporation in the same manner as other non-employee directors.
A copy of the Corporation’s news release announcing Dr. Smith’s appointment is attached hereto as Exhibit 99.1.
Item 9.01Financial Statements and Exhibits
|99.1||C&F Financial Corporation news release dated August 21, 2020|
Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized.
C&F FINANCIAL CORPORATION
August 21, 2020
/s/ Jason E. Long
Jason E. Long
Chief Financial Officer and Secretary